.22 to e15.90; 1 study85).

Skin complications. EVLA was associated with an
increased risk of ecchymosis than CAC (RR, 2.17; 95% CI,
1.39-3.37; 1 study76).
Outcomes at 1 year.
Anatomic closure. EVLA was associated with higher
anatomic closure rates than UGFS (RR, 1